ARHGEF12 and urinary bladder cancer: Collectively, these findings indicate that ARHGEF12 regulates cisplatin resistance in bladder cancer cells and underscore the precision of combining MR analysis with single-cell approaches to pinpoint candidate therapeutic targets.